Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × adavosertib × Clear all

NCT02593019 2021-03-19

Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients

Phase 2 Completed

Small Cell Lung Carcinoma

NCT02688907 2018-09-20

Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation

Phase 2 Terminated

Small Cell Lung Carcinoma